HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lennart Truedsson Selected Research

Hereditary Complement Deficiency Diseases

12/2018Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.
11/2015European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.
8/2015Heat differentiated complement factor profiling.
8/2010Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.
1/2009Genetic, molecular and functional analyses of complement factor I deficiency.
12/2007Complement deficiencies and systemic lupus erythematosus.
9/2007Complement analysis in the 21st century.
11/2006Properdin deficiency in a boy with fulminant meningococcal septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lennart Truedsson Research Topics

Disease

20Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 01/2004
10Infections
12/2018 - 07/2003
10Rheumatoid Arthritis
05/2015 - 01/2005
9Inflammation (Inflammations)
01/2019 - 08/2002
8Hereditary Complement Deficiency Diseases
12/2018 - 11/2006
6Autoimmune Diseases (Autoimmune Disease)
08/2012 - 02/2008
5Arthritis (Polyarthritis)
05/2015 - 01/2006
5Spondylarthropathies
05/2015 - 01/2006
3Vasculitis (Vasculitides)
01/2019 - 01/2005
2Lupus Nephritis
01/2019 - 02/2014
2Bacterial Infections (Bacterial Infection)
12/2018 - 07/2003
2Glomerulonephritis
12/2018 - 01/2005
2Acute Coronary Syndrome
10/2016 - 01/2009
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2016 - 01/2015
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 01/2016
2Necrosis
05/2015 - 07/2012
2Rheumatic Diseases (Rheumatism)
01/2014 - 08/2012
2Celiac Disease (Celiac Sprue)
01/2014 - 02/2005
2Disease Susceptibility (Diathesis)
07/2012 - 01/2004
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019
1Hereditary Angioedemas
12/2018
1Exanthema (Rash)
12/2018
1Multiple Organ Failure (MODS)
01/2016
1Pneumococcal Infections
05/2015
1Purine Nucleoside Phosphorylase Deficiency
01/2015
1Ataxia (Dyssynergia)
01/2015
1Proteinuria
01/2014
1Alopecia (Baldness)
01/2014
1Stroke (Strokes)
01/2014
1Primary Immunodeficiency Diseases
01/2014
1Pleurisy (Pleuritis)
01/2014
1Lymphopenia (Lymphocytopenia)
01/2014
1Thrombosis (Thrombus)
01/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2014
1Venous Thromboembolism
11/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2013
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2013
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2013
1Microscopic Polyangiitis
01/2013
1Kidney Diseases (Kidney Disease)
01/2011

Drug/Important Bio-Agent (IBA)

11Complement System Proteins (Complement)IBA
11/2022 - 11/2006
6AutoantibodiesIBA
01/2019 - 12/2007
6Antigen-Antibody Complex (Immune Complex)IBA
12/2018 - 01/2004
6Immunoglobulin G (IgG)IBA
08/2012 - 07/2003
5Methotrexate (Mexate)FDA LinkGeneric
01/2016 - 01/2006
5Proteins (Proteins, Gene)FDA Link
08/2015 - 09/2010
4Fibrinogen (Factor I)FDA Link
01/2019 - 01/2007
3AntibodiesIBA
01/2019 - 02/2005
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2015 - 07/2012
3Analgesics (Analgesic Drugs)IBA
05/2015 - 07/2012
3Conjugate VaccinesIBA
05/2015 - 01/2013
3Immunoglobulin A (IgA)IBA
01/2014 - 07/2003
3Polysaccharides (Glycans)IBA
08/2012 - 07/2006
3Immunoglobulins (Immunoglobulin)IBA
07/2012 - 07/2003
3CytokinesIBA
04/2011 - 03/2004
3Interferon Type IIBA
04/2011 - 09/2008
2VaccinesIBA
12/2018 - 12/2011
2Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
12/2018 - 12/2011
2ProperdinIBA
12/2018 - 11/2006
2Complement Factor H (Factor H)IBA
08/2015 - 01/2011
2AntigensIBA
02/2014 - 02/2005
2Antirheumatic Agents (DMARD)IBA
01/2013 - 07/2012
2Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA
07/2012 - 12/2011
2Complement Inactivating AgentsIBA
01/2011 - 01/2009
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2009 - 07/2006
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2007 - 01/2004
2HLA-DRB1 Chains (HLA DRB1)IBA
09/2006 - 01/2005
2MannansIBA
07/2006 - 01/2005
2Complement Factor B (Factor B)IBA
07/2006 - 07/2003
1Triglycerides (Triacylglycerol)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1P-SelectinIBA
10/2016
1Prasugrel HydrochlorideFDA Link
10/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2016
1CortisoneFDA Link
01/2016
1thymoglobulinFDA Link
01/2016
1Prednisolone (Predate)FDA LinkGeneric
05/2015
1Laminin (Merosin)IBA
02/2014
1LigandsIBA
02/2014
1Nucleosomes (Nucleosome)IBA
02/2014
1anti-dsDNA autoantibodyIBA
01/2014
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2014
1S100A12 ProteinIBA
11/2013
1Biological ProductsIBA
10/2013
1tocilizumab (atlizumab)FDA Link
10/2013
1Rituximab (Mabthera)FDA Link
10/2013
1Abatacept (Orencia)FDA Link
10/2013
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2013
1Complement C3 (C3 Complement)IBA
01/2013
1Myeloblastin (Proteinase 3)IBA
01/2013
1Peroxidase (Myeloperoxidase)IBA
01/2013
1Histones (Histone)IBA
08/2012
1Glycoside Hydrolases (Endoglycosidases)IBA
08/2012
1Tumor Necrosis Factor InhibitorsIBA
12/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011

Therapy/Procedure

2Hematopoietic Stem Cell Transplantation
01/2016 - 01/2015
1Transplantation
01/2016
1Therapeutics
08/2011